A single infusion of cetuximab was not associated with relief from therapy-resistant neuropathic pain.
Live-attenuated herpes zoster vaccine protects against postherpetic neuralgia even when [herpes zoster] occurs despite vaccination.
For patients with chronic inflammatory demyelinating polyradiculoneuropathy, the presence of neuropathic pain leads to worsened disability and disease outcome.
Updating the upper reference limits for CSF-TP according to age may aid in eliminating chances of misdiagnosing CIDP.
The occurrence of anti-myelin-associated glycoprotein (MAG) without IgM monoclonal gammopathy is possible in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
According to the results of a nested case-control study, oral fluoroquinolone exposure appears to be associated with an increased risk of incident peripheral neuropathy.
A structured medical management program was found to improve outcomes in patients with trigeminal neuralgia after 2 years.
According to the results of a recent review, there is “insufficient” evidence to conclude that either nutmeg or St John’s wort are effective in helping treat pain in neuropathic conditions.
Mirogabalin was found to be safe, well tolerated, and effective at alleviating postherpetic neuralgia-associated pain.
There is disagreement between clinical diagnosis and criteria-based diagnosis of fibromyalgia.